Impact of Empagliflozin on Subclinical Left Ventricular Dysfunctions and on the Mechanisms Involved in Myocardial Disease Progression in Type 2 Diabetes: Rationale and Design of the Empa-Heart Trial

AuthID
P-015-CM7
5
Author(s)
Nesti L.
·
Fabiani I.
·
Calogero E.
·
Di Bello V.
Document Type
Article
Year published
2017
Published
in Cardiovascular Diabetology
Volume: 16, Issue: 1
Indexing
Publication Identifiers
Pubmed: 29025406
Scopus: 2-s2.0-85030834144
Export Publication Metadata
Marked List
Citations
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.



CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.